How is Potocki-Lupski syndrome diagnosed?

Potocki-Lupski syndrome (PTLS) is diagnosed primarily through chromosomal microarray analysis (CMA), which identifies a specific microduplication on chromosome 17p11.2. Because the clinical presentation is broad and often overlaps with other developmental conditions, a definitive diagnosis requires specialized genetic testing to confirm the underlying genomic imbalance.

How is Potocki-Lupski syndrome diagnosed?

The diagnostic process for Potocki-Lupski syndrome typically begins when a pediatrician or specialist notes a constellation of symptoms, such as hypotonia, developmental delays, or failure to thrive. Because these features are non-specific, the "diagnostic odyssey" can be long and frustrating for families. A clinical geneticist will perform a physical examination and, upon suspicion, order a chromosomal microarray (CMA). This test is the gold standard for identifying the 17p11.2 duplication that defines Potocki-Lupski syndrome. In some cases, if initial array results are inconclusive but clinical suspicion remains high, whole-exome or whole-genome sequencing may be utilized.

What tests are involved in the diagnostic process?

Beyond genetic confirmation, clinicians use a multidisciplinary approach to assess the systemic impact of Potocki-Lupski syndrome. Diagnostic evaluations often include:

• Chromosomal Microarray (CMA): Detects the duplication of the 17p11.2 region.


• Echocardiogram: Essential to screen for structural heart defects, which occur in approximately 30-40% of cases.


• Sleep Study: Used to evaluate obstructive or central sleep apnea, a common concern in Potocki-Lupski syndrome patients.


• Audiological and Ophthalmological Exams: To assess for common sensory processing or structural vision and hearing issues.


• Neurodevelopmental Assessment: To document the specific profile of cognitive and social-communication delays.

Which specialists are involved in the diagnosis?

Due to the multisystem nature of Potocki-Lupski syndrome, diagnosis is usually coordinated by a clinical geneticist. However, initial concerns are often raised by primary care physicians, neurologists, or developmental pediatricians. Because 14 members of the DiseaseMaps.org community have shared their experiences, we know that many families consult several specialists—including cardiologists, speech-language pathologists, and physical therapists—before the genetic cause is identified. It is vital to seek out a geneticist or a major academic medical center if your local providers are unfamiliar with this rare condition, as prompt recognition allows for earlier intervention.

What conditions are in the differential diagnosis?

Because Potocki-Lupski syndrome shares features with other neurodevelopmental disorders, it is often initially misdiagnosed. Clinicians must distinguish it from conditions such as Smith-Magenis syndrome (which involves a deletion in the same 17p11.2 region), Autism Spectrum Disorder (ASD), Prader-Willi syndrome, and various other chromosomal microdeletion or microduplication syndromes. Distinguishing these requires high-resolution genetic testing rather than relying on physical symptoms alone.

Next steps

• Consult with a board-certified clinical geneticist to discuss microarray testing.


• Request a referral to a pediatric cardiologist to rule out structural heart anomalies.


• Connect with the 14 community members on DiseaseMaps.org to share experiences and find local resources.


• Keep a detailed medical journal of your child’s developmental milestones to assist your specialists.


• Reach out to organizations like the Potocki-Lupski Syndrome Foundation for vetted educational materials.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Potocki-Lupski syndrome.


• Orphanet: 17p11.2 duplication syndrome.


• OMIM (Online Mendelian Inheritance in Man): #610883 - Potocki-Lupski Syndrome.


• Potocki-Lupski Syndrome Foundation (PLSF) clinical resources.